# A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects

> **NCT03350321** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 162 (actual)

## Conditions studied

- Anemia
- Renal Insufficiency, Chronic

## Interventions

- **DRUG:** Molidustat (BAY85-3934)
- **DRUG:** Darbepoetin alfa

## Key facts

- **NCT ID:** NCT03350321
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-12
- **Primary completion:** 2019-05-17
- **Final completion:** 2019-10-11
- **Target enrollment:** 162 (ACTUAL)
- **Last updated:** 2021-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03350321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03350321, "A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03350321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*